Benchmark lowered the firm’s price target on Green Thumb Industries (GTBIF) to $10 from $14 and keeps a Buy rating on the shares. Green Thumb delivered “strong” Q4 results, outperforming consensus on both revenue and AEBITDA despite sector-wide pricing pressure and regulatory uncertainty, the analyst tells investors. Pricing headwinds remain a challenge, but the company’s cash flow strength and strategic investments “provide a competitive edge,” the analyst argues.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GTBIF:
- Green Thumb Industries to open RISE Dispensary Henderson in Nevada
- Strong Financial Performance and Strategic Expansion Drive Buy Rating for Green Thumb Industries
- Green Thumb Industries Reports Record Revenue and Expansion
- Green Thumb Industries Reports Strong 2024 Financial Results
- Green Thumb Industries Reports Strong Q4 2024 Financials